| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.034 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |